CRE Homepage About The CRE Advisory Board Newsletter Search Links Site Map Comments/Ideas
Reg Week Archives
Data Access
Data Quality
Regulation by Litigation
Regulation by Information
Regulation by Appropriation
Special Projects
CRE Watch List
Emerging Regulatory Issues
OMB Papers
Guest Column
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Interactive Public Docket
Electronic Regulatory Reform
Consumer Response Service
Site Search

Enter keyword(s) to search

CRE Watchlist: Special Projects
HHS/NTP Report on Carcinogens Program



Bitter Medicine: Pharmaceutical Listings in the Report on Carcinogens
Report claiming a neeed for a pharmaceutical category separate from NTP, which could provide a much fuller explanation of the risk and benefits of covered drug products, and would allow the public to make better informed decisions.

Letter to the Director of NIEHS
Letter from CRE to the Director of the National Institute of Environmental Health Sciences (NIEHS).

Attachment to Letter
The Need To Supplement Certain Listings In The Biennial Reports On Carcinogens In Order To Avoid Misleading The Public And Harming Public Health.